Exposure to wildfire smoke may increase the risk of developing several cancers, according to research presented at the AACR...
Amid disruption in Ukraine, international partnerships are preserving oncology progress—and building the foundation for long-term recovery.
An AACR grant to study menin's structure gave researchers the 3D map they needed to produce new treatments for...
At the AACR Annual Meeting 2026, National Cancer Institute Director Anthony Letai offered insights into what NCI considers to...
An AACR Patient Advocate Forum assembled a panel of experts to discuss how AI tools can help advance cancer...
In April 2026, AACR's journals editors highlighted studies on cancer survivors taking GLP-1 agonists, an immunotherapy-boosting bacteria, and more.
Patient advocates from the AACR Scientist↔Survivor Program shared their research on cancer during the AACR Annual Meeting 2026.
A recap of the last day of the AACR Annual Meeting 2026, including plenaries on innovative treatment modalities and...
Injecting immunotherapy directly into precancerous oral lesions may be an effective way to prevent progression to cancer without surgery.
A recap from the fifth day of the AACR Annual Meeting 2026, including a plenary on early-onset cancers, clinical...
People with alveolar soft part sarcoma can receive immunotherapy treatment for an extended period without long-term side effects.